Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy

Dirven, L.; Klarenbeek, N.B.; Broek, M. van den; Groenendael, J.H.L.M. van; Sonnaville, P.B.J. de; Kerstens, P.J.S.M.; ... ; Allaart, C.F. (2013)

Article / Letter to editor

• Alanine transferase (ALT)
• Methotrexate
• Rheumatoid arthritis

• All authors: Dirven, L.; Klarenbeek, N.B.; Broek, M. van den; Groenendael, J.H.L.M. van; Sonnaville, P.B.J. de; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C.; Lems, W.F.; Allaart, C.F.
• Date: 2013-05-31
• Journal: Clinical Rheumatology
• Volume: 32
• Issue: 5
• Pages: 585 - 590
• DOI: doi:10.1007/s10067-012-2136-8